Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. Reply
N Engl J Med
.
2021 Jan 14;384(2):189.
doi: 10.1056/NEJMc2033787.
Epub 2020 Dec 30.
Authors
Ajay Nirula
1
,
Lei Shen
2
,
Daniel M Skovronsky
2
Affiliations
1
Eli Lilly, San Diego, CA.
2
Eli Lilly, Indianapolis, IN
[email protected]
.
PMID:
33378611
DOI:
10.1056/NEJMc2033787
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Neutralizing*
Antibodies, Viral
COVID-19*
Humans
Outpatients
SARS-CoV-2
Substances
Antibodies, Neutralizing
Antibodies, Viral